How to research colorectal cancer treatment options

I built the first version of Firstlight while researching options for my mom, Judy, during her colorectal cancer. I'm not a doctor. What I could do was dig carefully, write down what I found with its sources, and bring it to the people who could judge it. This guide is that process, generalized — and a reminder of its one hard limit: this is not medical advice, and none of it replaces your oncology team.

Start with the specifics, not the diagnosis word

"Colorectal cancer" is the start of the question, not the answer. Treatment paths diverge sharply based on details that are on your pathology and molecular reports. The things worth knowing — and asking your team to explain — include:

• Location and stage — colon vs rectal, and how far it has spread, change the standard approach.
• MSI / MMR status — whether the tumor is microsatellite-instability-high (MSI-H) or mismatch-repair-deficient (dMMR) can open the door to different therapy classes.
• Key mutations — markers like KRAS, NRAS, BRAF, and HER2 status are frequently the dividing line for which drugs and trials apply.
• Treatments already given — what's been tried, and the response, shapes what comes next and which trials accept you.

You don't need to interpret these yourself. You need to know they exist, have them written down, and use them to focus everything that follows.

Go to trusted sources first

Skip the forums-as-fact and miracle-cure pages. Anchor your research in sources that cite evidence:

• National Cancer Institute (cancer.gov) — its PDQ summaries explain standard treatment by stage in patient and clinician versions.
• NCCN patient guidelines — plain-language versions of the guidelines many oncologists follow.
• ClinicalTrials.gov — for trials that match the specifics above. (See how to read a listing.)
• PubMed — for the underlying studies, once you know what you're looking for.

If something you read elsewhere can't be traced back to sources like these, treat it as a lead to verify, not a fact.

Tell standard of care apart from "emerging"

As you read, sort what you find into two buckets: the established standard of care for the specific situation, and emerging options (newer drugs, combinations, or trials). Both belong in the conversation — but conflating them is how families end up chasing something promising and unproven while overlooking the proven path. Let your oncologist weigh them.

We brought a drug combination from recent trials to Mom's oncologist, and he agreed it was worth trying. The point was never that I'd found the answer — it was that I'd found something specific and sourced enough for an expert to act on.

Turn it into questions, then bring them in

For colorectal cancer specifically, useful questions to prepare include: Has the tumor been tested for MSI/MMR and the key mutations? Does the standard of care change based on those results? Are there trials that fit this exact profile? What's the goal of the next line of treatment, and what are the trade-offs?

Bring your written findings, the sources, and these questions to the appointment. The job isn't to decide — it's to make sure nothing relevant goes unseen.

← Back to the blog  ·  Read: how to stay on top of new research →